Evidence map›Paper›PMID 24867402›Full record

ArticlePloS one2014

Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.

Alethea W McCormick, Nadia N Abuelezam, Erin R Rhode, Taige Hou, Rochelle P Walensky, Pamela P Pei, Jessica E Becker, Madeline A DiLorenzo, Elena Losina, Kenneth A Freedberg and 2 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Relative Impact of Community and Hospital Antibiotic Use on the Selection of Extended-spectrum Beta-lactamase-producing Escherichia coli.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  10. Article
  11. Article
  12. Using Observational Data to Calibrate Simulation Models.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alethea W McCormickDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Nadia N AbuelezamDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Erin R RhodeDivisions of General Medicine and Infectious Disease and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Taige HouDivisions of General Medicine and Infectious Disease and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Rochelle P WalenskyDivisions of General Medicine and Infectious Disease and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Center for AIDS Research, Harvard University, Boston, Massachusetts, United States of America.
Pamela P PeiDivisions of General Medicine and Infectious Disease and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Jessica E BeckerDivisions of General Medicine and Infectious Disease and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Madeline A DiLorenzoDivisions of General Medicine and Infectious Disease and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Elena LosinaDepartments of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America; Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Kenneth A FreedbergDivisions of General Medicine and Infectious Disease and the Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Center for AIDS Research, Harvard University, Boston, Massachusetts, United States of America; Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Marc LipsitchDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; Center for Communicable Disease Dynamics and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
George R SeageDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.

Funding

Optimizing HIV Care in Less Developed CountriesR01AI058736 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Kenneth Alan Freedberg, Emily Parker Hyle · 2004 to 2026
$21.5M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
Cost-effectiveness of preventing HIV complicationsR37AI042006 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI FREEDBERG, KENNETH ALAN · 2006 to 2014
$7.1M
Epidemiology of Infectious Diseases and BiodefenseT32AI007535 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRAD, YONATAN H, MURRAY, MEGAN B · 1998 to 2025
$4.8M
Modeling the Impact of HIV Prevention InterventionsR01MH087328 · NIMH · HARVARD SCHOOL OF PUBLIC HEALTH · PI SEAGE, GEORGE R · 2010 to 2013
$2.7M
NIAID NIH HHS R01 AI058736NIAID NIH HHS R01-AI-058736NIAID NIH HHS R37 AI042006NIAID NIH HHS T32 AI007433NIAID NIH HHS T32-AI-007433NIAID NIH HHS T32 AI007535NIAID NIH HHS T32-AI-007535NIMH NIH HHS R01-MH-087326NIMH NIH HHS R01 MH087328
6 · The paper itself

Abstract

Understanding HIV transmission dynamics is critical to estimating the potential population-wide impact of HIV prevention and treatment interventions. We developed an individual-based simulation model of the heterosexual HIV epidemic in South Africa and linked it to the previously published Cost-Effectiveness of Preventing AIDS Complications (CEPAC) International Model, which simulates the natural history and treatment of HIV. In this new model, the CEPAC Dynamic Model (CDM), the probability of HIV transmission per sexual encounter between short-term, long-term and commercial sex worker partners depends upon the HIV RNA and disease stage of the infected partner, condom use, and the circumcision status of the uninfected male partner. We included behavioral, demographic and biological values in the CDM and calibrated to HIV prevalence in South Africa pre-antiretroviral therapy. Using a multi-step fitting procedure based on Bayesian melding methodology, we performed 264,225 simulations of the HIV epidemic in South Africa and identified 3,750 parameter sets that created an epidemic and had behavioral characteristics representative of a South African population pre-ART. Of these parameter sets, 564 contributed 90% of the likelihood weight to the fit, and closely reproduced the UNAIDS HIV prevalence curve in South Africa from 1990-2002. The calibration was sensitive to changes in the rate of formation of short-duration partnerships and to the partnership acquisition rate among high-risk individuals, both of which impacted concurrency. Runs that closely fit to historical HIV prevalence reflect diverse ranges for individual parameter values and predict a wide range of possible steady-state prevalence in the absence of interventions, illustrating the value of the calibration procedure and utility of the model for evaluating interventions. This model, which includes detailed behavioral patterns and HIV natural history, closely fits HIV prevalence estimates.

Indexed as

Models, BiologicalPatient-Specific ModelingBayes TheoremCalibrationFemaleHeterosexualityHIV InfectionsHumansMalePrevalenceRisk FactorsSexual BehaviorSexual PartnersSouth Africa

Identifiers

PMID24867402
PMCPMC4035281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.